Médecins Sans Frontières launched a hepatitis C programme in Cambodia in May 2016, offering the first free treatment for the blood-borne virus in the country. Although the prevalence of the disease is unknown, it is estimated that between 2 and 5 per cent of the population is infected.
Our malaria research project in northern Cambodia was set up to find ways to eliminate malaria in an area where there is proven resistance to the most powerful antimalarial drug, artemisinin.
MSF teams responded to the coronavirus COVID-19 pandemic in the country between February and June 2020, in which training and technical support was provided in six hospitals.